ABVC
NASD ABVC BioPharma, Inc.$0.0000 ↓ -1.0000 (-100.00%) Trading Down from the previous close of $1.0000
- YTD change
- N/A
- vs 20-day SMA
- N/A
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-0.18 (-15.25%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $116.9000
- ABVC is down 100% since the beginning of the year
- ABVC is down 100% over the past 12 months
- ABVC is down 100% over the past 1 month
- 2% of all ABVC investors are betting against ABVC
ABVC reads poor: the 12-month move is -64.5%.
- Previous minute
- N/A
- Last hour
- N/A
- Last 5 days
- N/A
- vs 8-day SMA
- N/A
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
